The new policies include a six-month delay on some research papers and mandate several approval steps before publishing. This process slows down the researchers from sharing their work. Former ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Broadcom (NASDAQ: AVGO). To learn more, check ...

Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...

Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...

Singapore researchers are using Google DeepMind’s AlphaFold to understand the intricate protein interactions at play in ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Marchant, who joined Primark in 2009, left after the company hired lawyers to investigate “an allegation made by an ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...